Shantou University Medical College
16
4
4
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.5%
2 terminated/withdrawn out of 16 trials
66.7%
-19.8% vs industry average
13%
2 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors
Role: lead
Comprehensive Care of Sleep Disordered Breathing
Role: collaborator
Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index
Role: collaborator
Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular Carcinoma
Role: lead
Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial Infarction
Role: lead
Evaluating the Analgesic Efficacy of Oxycodone Hydrochloride in Pediatric Laparoscopic Cryptorchidism Surgery
Role: lead
Effect of Intelligent Intervention Strategies on Self-efficacy and Hospital Readiness of Parents of Preterm Infants
Role: lead
The Development of Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale
Role: lead
Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma
Role: lead
Preoperative Visual Aids on Glaucoma Surgical Patients
Role: collaborator
Randomized Study of Adjuvant Radiotherapy After Curative Resection of HCC With Narrow Margin (RAISE)
Role: collaborator
Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer
Role: lead
Rehabilitation Training Participated by Caregivers in Ischemic Stroke: a Randomized Controlled Trial to Test the Effect of Home-based Rehabilitation Intervention on Physical Function.
Role: lead
Study on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical Bioinformatics
Role: collaborator
Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer
Role: lead
Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer
Role: lead
All 16 trials loaded